Management of sexually transmissible infections during pregnancy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy; D002690:Chlamydia Infections / Q000188:drug therapy; D003075:Coitus; D003218:Condylomata Acuminata / Q000601:surgery; D003354:Corynebacterium Infections / Q000188:drug therapy; D005260:Female; D005831:Genital Diseases, Female / Q000209:etiology; D006069:Gonorrhea / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D008795:Metronidazole / Q000627:therapeutic use; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000150:complications / Q000209:etiology / Q000628:therapy*; D012749:Sexually Transmitted Diseases / Q000628:therapy*; D013290:Streptococcal Infections / Q000188:drug therapy; D013587:Syphilis / Q000188:drug therapy; D014247:Trichomonas Vaginitis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D010401:Penicillin G Benzathine